Attached files
| file | filename |
|---|---|
| 8-K - Travere Therapeutics, Inc. | e612106_8k-retrophin.htm |
April 4, 2014
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Retrpohin, Inc. under Item 4.01 of its Form 8-K dated March 31, 2014. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Retrpohin, Inc. contained therein.
Very truly yours,
/s/ Marcum llp
Marcum llp